Skip to content

Industry News: Medcac Meetings

Thursday, January 07, 2010

CMS is pleased to announce the posting of 2010 Physician Quality Reporting Initiative (PQRI) educational products to the PQRI webpage at www.cms.hhs.gov/PQRI.

Thursday, January 07, 2010

CMS is hosting a Listening Session on the 2011 Physician Quality Reporting Initiative (PQRI).

Thursday, January 07, 2010

This Special Open Door Forum will focus on a new reporting option, available for the 2010 PQRI and eRx Incentive Program, known as the Group Practice Reporting Option (GPRO). Group practices that are interested in participating in the GPRO for PQRI and/or the eRx Incentive Program must submit a self-nomination letter to CMS by no later than January 31, 2010.

Wednesday, January 06, 2010

In its Semiannual Report to Congress, the Department of HHS Office of Inspector General (OIG) today announced significant audit, investigation, and evaluation accomplishments for FY 2009. OIG reported savings and expected recoveries of $20.97 billion for all of FY 2009.

The following areas pertaining to laboratories were identified in the report:

  • End Stage Renal Disease: Separately Billed Laboratory Tests for Medicare Beneficiaries
Wednesday, January 06, 2010

The Agency for Healthcare Research and Quality's (AHRQ) Technology Assessment Program will be posting a draft technology assessment for review on December 16, 2009. This draft is entitled "Update of Horizon Scan Reports of Genetic Tests Currently Available for Clinical Use." If you are interested in reviewing this document, please visit: http://www.ahrq.gov/clinic/ta/tareview.htm. The document will be available for review from 9:00 AM on December 16, 2009 to 5:00 PM on January 8, 2010. If you have any questions, please contact ahrqtap@ahrq.hhs.gov.

Wednesday, January 06, 2010

Issue

CMS has called this meeting of the panel to consider and make recommendations to CMS regarding the evidence that supports the use of pharmacogenomic testing in the diagnosis and treatment of cancer. Currently, Medicare does not have a National Coverage Determination for using such tests for diagnosis or treatment of cancer.